BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,163,497 | -20.6% | 23,168 | -0.1% | 0.15% | -27.2% |
Q2 2023 | $1,465,861 | +40.5% | 23,194 | +0.0% | 0.20% | +43.3% |
Q1 2023 | $1,043,093 | -18.2% | 23,185 | -20.4% | 0.14% | -31.9% |
Q4 2022 | $1,275,660 | +7.8% | 29,118 | +62.2% | 0.21% | +15.6% |
Q3 2022 | $1,183,000 | +378.9% | 17,948 | +363.3% | 0.18% | +752.4% |
Q1 2022 | $247,000 | -94.5% | 3,874 | -91.6% | 0.02% | -93.5% |
Q1 2021 | $4,473,000 | -27.4% | 46,000 | -16.2% | 0.32% | -22.8% |
Q4 2020 | $6,159,000 | +3.0% | 54,918 | -14.9% | 0.42% | +5.3% |
Q3 2020 | $5,979,000 | +11.1% | 64,500 | -6.6% | 0.40% | +7.9% |
Q2 2020 | $5,384,000 | -3.7% | 69,031 | -27.8% | 0.37% | -17.4% |
Q1 2020 | $5,592,000 | +14.4% | 95,627 | +56.8% | 0.44% | +47.2% |
Q4 2019 | $4,887,000 | +15.3% | 61,000 | +5.7% | 0.30% | +19.4% |
Q3 2019 | $4,239,000 | -22.1% | 57,700 | +0.1% | 0.25% | -21.5% |
Q2 2019 | $5,439,000 | – | 57,660 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |